Data gathered: November 22
AI Stock Analysis - Edwards Lifesciences (EW)
Analysis generated October 24, 2024. Powered by Chat GPT.
Edwards Lifesciences Corporation is a prominent American medical equipment company. Renowned for its innovative heart valve products, it primarily designs, manufactures, and markets technologies for structural heart disease, especially in relation to critical care and surgical monitoring. The company’s key product lines include transcatheter heart valves, surgical heart valves, and critical care products. With a focus on heart-related medical devices, Edwards Lifesciences serves a critical role in the healthcare sector and sees steady demand for its life-saving technologies.
Stock Alerts - Edwards Lifesciences (EW)
 |
Edwards Lifesciences | November 14 Insider Alert: BOBO DONALD E JR is selling shares |
|
Edwards Lifesciences | November 13 Job postings are down by 25.2% in the last couple of days. |
|
Edwards Lifesciences | November 12 Ro Khanna (member of U.S. congress) is buying shares |
|
Edwards Lifesciences | November 5 Job postings are down by 34.4% in the last couple of days. |
Alternative Data for Edwards Lifesciences
About Edwards Lifesciences
Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve.
| Price | $70.48 |
| Target Price | Sign up |
| Volume | 2,600,000 |
| Market Cap | $41.4B |
| Year Range | $59.7 - $95.56 |
| Dividend Yield | 0% |
| PE Ratio | 27.06 |
| Analyst Rating | 33% buy |
| Industry | Medical Devices |
In the news
EW STOCK NEWS: Edwards Lifesciences Stock Plummeted 31% - Contact BFA Law about the Class Action Lawsuit if You Suffered Losses (NYSE:EW)November 22 - GlobeNewswire |
|
 |
Empowered Funds LLC Purchases 2,324 Shares of Edwards Lifesciences Co. (NYSE:EW)November 22 - ETF Daily News |
EW LAWSUIT ALERT: Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming DeadlineNovember 21 - GlobeNewswire |
|
Edwards Lifesciences (EW) Faces Investor Class Action Over Loss of $16 Billion Of Market Capitalization – Hagens BermanNovember 21 - GlobeNewswire |
|
|
Edwards Lifesciences Co. (NYSE:EW) Shares Sold by Natixis Advisors LLCNovember 21 - ETF Daily News |
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud LawsuitNovember 20 - Finnhub |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 1.38B | 717M | 1.09B | 3.07B | 403M | 0.670 |
| Q2 '24 | 1.4B | 736M | 1.1B | 366M | 404M | 0.700 |
| Q1 '24 | 1.61B | 875M | 1.21B | 352M | 526M | 0.660 |
| Q4 '23 | 1.49B | 842M | 1.18B | 370M | 368M | 0.640 |
| Q3 '23 | 1.5B | 790M | 993M | 385M | 423M | 0.590 |
Insider Transactions View All
| BOBO DONALD E JR filed to sell 46,936 shares at $65.6. November 13 '24 |
| Wood Larry L filed to sell 198,526 shares at $65.9. November 5 '24 |
| BOBO DONALD E JR filed to sell 46,936 shares at $69.5. October 15 '24 |
| BOBO DONALD E JR filed to sell 46,936 shares at $66.8. September 11 '24 |
| Chopra Daveen filed to sell 29,333 shares at $70. August 20 '24 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Ro Khanna |
Nov 11, 24 | Buy | $1K - $15K |
| Ro Khanna |
Oct 8, 24 | Buy | $1K - $15K |
| Mike Kelly |
Jun 14, 24 | Sell | $1K - $15K |
Read more about Edwards Lifesciences (EW) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Edwards Lifesciences?
The Market Cap of Edwards Lifesciences is $41.4B.
What is Edwards Lifesciences' PE Ratio?
As of today, Edwards Lifesciences' PE (Price to Earnings) ratio is 27.06.
What is the current stock price of Edwards Lifesciences?
Currently, the price of one share of Edwards Lifesciences stock is $70.48.
How can I analyze the EW stock price chart for investment decisions?
The EW stock price chart above provides a comprehensive visual representation of Edwards Lifesciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Edwards Lifesciences shares. Our platform offers an up-to-date EW stock price chart, along with technical data analysis and alternative data insights.
Does EW offer dividends to its shareholders?
As of our latest update, Edwards Lifesciences (EW) does not offer dividends to its shareholders. Investors interested in Edwards Lifesciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Edwards Lifesciences?
Some of the similar stocks of Edwards Lifesciences are Boston Scientific, Intuitive Surgical, Medtronic, Stryker, and Becton Dickinson and Co.
.